Clinical Trial Update: Rituximab Combined With Cyclosporine Versus Rituximab Alone in the Treatment of iMN [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rituximab plus cyclosporine versus rituximab alone for idiopathic membranous nephropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Membranous Nephropathy

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Rituxan (rituximab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Idiopathic Membranous Nephropathy | Phase 3 | Status: TERMINATED